Schering-Plough’s new trial model
This article was originally published in The Tan Sheet
Executive Summary
A new global model for clinical trial operations will be adopted by Schering-Plough to improve the planning and management of the progression of therapeutic compounds during the clinical trial process. The Global Clinical Harmonization program is "designed to maximize its product portfolio through centralized global processes and function units that are efficient, compliant and customer-focused," the company states in a release June 6. The Global Clinical Operations will establish a "global set of standards, policies and practices, and build a management system that will oversee clinical trials worldwide," the firm explains. All trials will be held to these standards regardless of trial type, phase or geography. The adoption of the new model marks another step in Schering-Plough's Action Agenda to build the firm into a "high-performance competitor for the long term," according to Chairman and CEO Fred Hassan. The firm recently began a consolidation of its operating facilities which will affect approximately 1,100 positions and close the Manati, Puerto Rico manufacturing site (1"The Tan Sheet" June 5, 2006, In Brief)...